TriplePoint Venture Growth BDC Corp.

TPVG
$4.44 (+ $0.02 + 0.45%)
Last updated: 2026-07-26 08:23 UTC
TPVG Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorFinancial Services
IndustryAsset Management
ISINUS89677Y1001
CUSIP89677Y100
Market Price4.44
Dividend Yield 17.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 1.0
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyQuarterly
P/E Ratio7.61
EPS0.83
Market Cap$255.3M
Book Value8.79
Price to Book0.719
Beta1.39
52w High8.2
52w Low5.24
Next Earnings DateN/A

TriplePoint Venture Growth BDC Corp. trades under ticker TPVG on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Financial Services exposure. Identifiers: ISIN US89677Y1001, CUSIP 89677Y100. Also searched as TriplePoint Venture Growth BDC.

Related researchTPVG stock priceTPVG share priceTPVG dividend historyTPVG dividend yieldTriplePoint Venture Growth BDC dividend historyTriplePoint Venture Growth BDC dividend yield89677Y100TriplePoint Venture Growth BDC stockTriplePoint Venture Growth BDC share price
About the Company
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Price History